-
All Hubei's cities, counties outside Wuhan rated as low risk
chinadaily
March 20, 2020
All the cities and counties in Central China's Hubei province had been labeled as low risk except for Wuhan, the epicenter of the COVID-19 outbreak in China, by the end of March 18, said local authorities.
-
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments
prnewswire
March 20, 2020
The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic.
-
Coronavirus (COVID-19) Update: FDA Focuses on Safety of Regulated Products While Scaling Back Domestic Inspections
fda
March 20, 2020
Protecting the health and safety of our staff and their families is of paramount concern to the U.S. Food and Drug Administration.
-
U.S. Approves Abbott Labs Coronavirus Test For Hospital Use
forbes
March 20, 2020
Abbott Laboratories won U.S. approval for its molecular test for the Coronavirus strain COVID-19, which will be used by hospitals and academic medical centers to speed diagnostic capabilities ...
-
Free EDC software for non-profit COVID-19 related studies
worldpharmanews
March 20, 2020
Italy-based EDC provider, Nubilaria srl, offers its ACTide EDC pro-bono for European non-profit COVID-19 Coronavirus related studies.
-
Understanding how COVID-19 affects children vital to slowing pandemic
worldpharmanews
March 20, 2020
Though COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately.
-
Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs
PRNewswire
March 20, 2020
Mylan N.V. (NASDAQ: MYL) today announced its continued commitment to do its part in support of public health needs amidst the evolving COVID-19 pandemic.
-
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
americanpharmaceuticalreview
March 20, 2020
Biomerica has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in 10 minutes that can be performed ...
-
EC offers €80m to CureVac for COVID-19 vaccine development
europeanpharmaceuticalreview
March 20, 2020
The European Commision (EC) has announced €80 million of support to aid in the R&D and production of a COVID-19 coronavirus vaccine.
-
“Harmonised approach” promoted for COVID-19 treatment clinical trials
europeanpharmaceuticalreview
March 20, 2020
The EMA has urged that the research community prioritise large randomised controlled studies for COVID-19 treatments and vaccines.